In cisplatin-resistant ovarian cancer cells, m7G modification significantly enhances translation of EGFR pathway genes and activates PI3K/AKT/mTOR signaling, which reduces apoptosis sensitivity (47). The gene discussed is MTOR; the disease is ovarian cancer.